Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort
- Resource Type
- Source
- PLoS ONE
PLOS ONE
PLoS ONE, Vol 11, Iss 3, p e0151703 (2016)
PLoS One, Vol. 11, no. 3, p. e0151703 [1-20] (2016) - Subject
Genetics and Molecular Biology (all) Male Chronic Hepatitis Hepacivirus Ribavirin/adverse effects Asthenia/chemically induced Polyethylene Glycol Biochemistry Polyethylene Glycols Body Mass Index Chronic Liver Disease 0302 clinical medicine Neutropenia/chemically induced Interferon-alpha/adverse effects Medicine Chronic lcsh:Science Liver Diseases virus diseases Antiviral Agents/adverse effects Cohort Science & Technology - Other Topics 030211 gastroenterology & hepatology Drug Therapy, Combination Cohort study Human medicine.medical_specialty Alpha interferon Gastroenterology and Hepatology Antiviral Agents Microbiology Dose-Response Relationship 03 medical and health sciences Pharmacotherapy Hepatitis C, Chronic/drug therapy Dose Prediction Methods Drug Therapy Anemia/chemically induced Humans Hemoglobin Aged Medicine and health sciences Biochemistry, Genetics and Molecular Biology (all) Hepaciviru Science & Technology Dose-Response Relationship, Drug Flaviviruses lcsh:R Organisms Biology and Life Sciences Proteins medicine.disease digestive system diseases chemistry Agricultural and Biological Sciences (all) Withholding Treatment Asthenia Immunology Proportional Hazards Model lcsh:Q Human medicine RNA viruses Physiology lcsh:Medicine Peginterferon-alfa Polyethylene Glycols/adverse effects Adult Anemia Cohort Studies Female Hepatitis C, Chronic Host-Pathogen Interactions Interferon-alpha Middle Aged Neutropenia Outcome Assessment (Health Care) Proportional Hazards Models RNA, Viral Recombinant Proteins Ribavirin Medicine (all) chemistry.chemical_compound Outcome Assessment, Health Care Medicine and Health Sciences 030212 general & internal medicine Viral Pathology and laboratory medicine Multidisciplinary biology Hepatitis C virus Pharmaceutics Hepatitis C Hematology Recombinant Protein Outcome Assessment (Health Care)/methods Medical microbiology Host-Pathogen Interaction Multidisciplinary Sciences Physiological Parameters Research Design Combination Viruses Drug Pathogens Host-Pathogen Interactions/drug effects Research Article Clinical Research Design Research and Analysis Methods Internal medicine Recombinant Proteins/adverse effects RNA, Viral/blood Antiviral Agent business.industry Body Weight Hepacivirus/drug effects Viral pathogens biology.organism_classification Hepatitis viruses Microbial pathogens RNA Adverse Events Cohort Studie business - Language
- ISSN
- 1932-6203